Tricuspid stenosis cardiac catheterization

Revision as of 02:43, 10 March 2014 by Twinkle Singh (talk | contribs)
Jump to navigation Jump to search

Tricuspid stenosis Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Tricuspid stenosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Tricuspid stenosis cardiac catheterization On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tricuspid stenosis cardiac catheterization

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tricuspid stenosis cardiac catheterization

CDC on Tricuspid stenosis cardiac catheterization

Tricuspid stenosis cardiac catheterization in the news

Blogs on Tricuspid stenosis cardiac catheterization

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Tricuspid stenosis cardiac catheterization

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Cardiac Catheterization

During diastole, there is a gradient between the right atrial (RA) and right ventricular (RV) diastolic pressure (RA is higher than RVEDP). A large a wave may be seen on the RA tracing.

  • Cardiac cathertization:
    • In the older pre-surgery population, this may be necessary in order to assess concomitant artery disease.
    • Cathertization of the right heart:
      • Used as a tool to evaluate the gradient across the valve and valve area
      • Used in diagnosis of associated congenital defects
    • Cathertization of the left heart:
      • Useful when assessing aortic and mitral valves in patients with rheumatic disease

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary[1]

Class IIb
"1. Invasive hemodynamic assessment of severity of TS may be considered in symptomatic patients when clinical and noninvasive data are discordant. (Level of Evidence: C)"

References

  1. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA; et al. (2014). "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0000000000000029. PMID 24589852.

Template:WH

Template:WS